FdaApplication
ANDA 219684
Identifiers
- fda_app_no: ANDA219684
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | ANDA |
| approval_date | 2025-09-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KETAMINE HYDROCHLORIDE | KETAMINE HYDROCHLORIDE | EQ 50MG BASE/5ML (EQ 10MG BASE/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS |
| KETAMINE HYDROCHLORIDE | KETAMINE HYDROCHLORIDE | EQ 100MG BASE/10ML (EQ 10MG BASE/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS |
2 products